Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and need for prescribing anti-inflammatory topical drops to patients undergoing laser peripheral iridotomy.


Clinical Trial Description

Primary closed angle glaucoma is responsible to almost half glaucoma related blindness around the world. Laser peripheral iridotomy (LPI) is a common and simple treatment used for both treatment and prevention of acute angle closure event.

Anti-inflammatory drops are commonly prescribed to patients undergoing LPI in order to prevent or reduce post-treatment discomfort. However, to date, there are no specific guidelines for post LPI anti-inflammatory treatment, nor sufficient clinical evidence regarding the efficacy of such treatment.

In the current study, the investigators aim to evaluate the effect of topical steroids and non-steroidal anti-inflammatory drugs (NSAIDs) on post LPI symptoms and inflammation markers. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02955641
Study type Interventional
Source Sheba Medical Center
Contact Ari Leshno, MD
Phone +972-3-5302874
Email ari.leshano@sheba.health.gov.il
Status Recruiting
Phase N/A
Start date November 1, 2016
Completion date November 2019

See also
  Status Clinical Trial Phase
Completed NCT03187821 - Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure N/A
Active, not recruiting NCT00153699 - Relationship Between Topiramate Use and Ocular Angle Status Phase 4
Completed NCT04683055 - Phaco-Trabeculotomy Vs Phaco-Trabeculectomy N/A
Recruiting NCT02613013 - Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure N/A
Recruiting NCT04602923 - Keratometric Change After XEN, Trabeculectomy and Tube Shunts N/A
Completed NCT06143943 - Anterior Segment Anatomic Parameters for Risk Profiling of Primary Angle-closure Glaucoma
Terminated NCT01151904 - Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients Phase 4
Recruiting NCT05251792 - Macular Pigment Optical Density in Primary Angle-closure Disease
Active, not recruiting NCT04878458 - Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma N/A
Not yet recruiting NCT05593354 - MicroPulse TLT - UK Study
Completed NCT02376725 - Comparing Phaco/IOL Versus Phaco/IOL + Goniosynechialysis in Subjects With PACG N/A
Active, not recruiting NCT00567788 - Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study N/A
Recruiting NCT03323138 - Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma N/A
Recruiting NCT04703712 - Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy N/A
Not yet recruiting NCT02964676 - Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure Glaucoma N/A
Recruiting NCT02959242 - Dresden Glaucoma and Treatment Study (DGTS)
Completed NCT01298635 - Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG) N/A
Completed NCT00051181 - A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma Phase 3
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Recruiting NCT05332665 - AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification